Tweet
<img alt="" height="1" width="1" />
Glaxo Wins US Approval for Diabetes Treatment Albiglutide
Wall Street Journal
Albiglutide was approved for use in Europe in March under the brand name Eperzan. It belongs to a class of drugs called GLP-1 receptor agonists, which work by stimulating the body's natural production of insulin and help regulate blood-sugar levels.
FDA Approves Weekly Injectable Diabetes Drug: AlbiglutideMedscape
FDA Approves Tanzeum to Treat Type 2 DiabeteseNews Park Forest
Tanzeum Approved for Type 2 DiabetesHealthDay
NASDAQ -Reuters -FierceBiotech
all 20 news articles »
More...